1
|
Inhibition of host cell apoptosis by Toxoplasma gondii is accompanied by reduced activation of the caspase cascade and alterations of poly(ADP-ribose) polymerase expression.
|
J Cell Sci
|
2001
|
1.23
|
2
|
Ivermectin-facilitated immunity in onchocerciasis. Reversal of lymphocytopenia, cellular anergy and deficient cytokine production after single treatment.
|
Clin Exp Immunol
|
1992
|
1.22
|
3
|
Ivermectin-facilitated immunity in onchocerciasis; activation of parasite-specific Th1-type responses with subclinical Onchocerca volvulus infection.
|
Clin Exp Immunol
|
1994
|
1.19
|
4
|
The diverse expression of immunity in humans at distinct states of Onchocerca volvulus infection.
|
Immunology
|
1997
|
1.06
|
5
|
Subclass-specific serological reactivity and IgG4-specific antigen recognition in human echinococcosis.
|
Trop Med Int Health
|
1997
|
1.05
|
6
|
Regulatory effects of Th1-type (IFN-gamma, IL-12) and Th2-type cytokines (IL-10, IL-13) on parasite-specific cellular responsiveness in Onchocerca volvulus-infected humans and exposed endemic controls.
|
Immunology
|
1999
|
0.89
|
7
|
Invasion by Toxoplasma gondii protects human-derived HL-60 cells from actinomycin D-induced apoptosis.
|
Med Microbiol Immunol
|
1999
|
0.88
|
8
|
Reactivation of chronic toxoplasmosis: is there a link to strain-specific differences in the parasite?
|
Behring Inst Mitt
|
1997
|
0.88
|
9
|
Regulation of developmental differentiation in the protozoan parasite Toxoplasma gondii.
|
J Eukaryot Microbiol
|
1996
|
0.86
|
10
|
Comparative immunoglobulin G antibody profiles between mother and child (CGMC test) for early diagnosis of congenital toxoplasmosis.
|
J Clin Microbiol
|
2000
|
0.84
|
11
|
Toxoplasmosis: from clinics to basic science.
|
Parasitol Today
|
1998
|
0.82
|
12
|
Bradyzoite-specific expression of a P-type ATPase in Toxoplasma gondii.
|
Mol Biochem Parasitol
|
2001
|
0.79
|
13
|
Toxoplasma gondii inhibits the in vitro induced apoptosis of HL-60 cells.
|
Tokai J Exp Clin Med
|
1998
|
0.77
|
14
|
Antigenicity and specificity of very low molecular weight Onchocerca volvulus polypeptides in the range 2.2-12.5 kD.
|
Trop Med Int Health
|
1997
|
0.75
|